Form 4: UnitedHealth Group Director Charles D. Baker Reports Acquisition of Deferred Stock Units

Director Charles D. Baker reports acquisition of deferred stock units as part of quarterly compensation for service on the UnitedHealth Group Board.

Summary

• On April 1, 2024, Charles D. Baker, a director of UnitedHealth Group, acquired 179 shares of common stock in the form of deferred stock units.
• These units were granted as regular quarterly compensation for his service as a director.
• The price per share was $0.
• The deferred stock units are immediately vested but must be retained until completion of service on the Board.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and alignment of interests.

Positives

• The acquisition of deferred stock units reflects continued alignment of director compensation with company performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Director compensation through stock grants is a common practice in publicly traded companies to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• Equity-based compensation, such as deferred stock units, is designed to incentivize long-term value creation.
• The specific amount and structure of equity grants vary widely based on company size, industry, and individual director responsibilities.
• Comparing UnitedHealth Group's director compensation practices to those of its peers (e.g., CVS Health, Anthem, Cigna) would provide a more comprehensive assessment.

Stakeholder Impact

• The acquisition of deferred stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates